UNSPSC 51281625: Telavancin

This classification denotes an antibiotic with the molecular formula C80H106Cl2N11O27P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XK134822Z0, chemically known as vancomycin, n3-(2-(decylamino)ethyl)-29-(((phosphonomethyl)amino)methyl)- but generally known as telavancin, which bears US NIH Compound Identifier 3081362. European Medicines Agency schedules Telavancin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB26698.

UNSPSC 51281625 Telavancin, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The source records show solicitations for naloxone and drug deactivation systems (Seminole County, Florida), medical and first aid supplies for fire rescue (City of Tampa), generic multi-source pharmaceuticals and OTC products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance), and a request for information on direct-to-manufacturer prescription programs (Texas Health and Human Services Commission). Telavancin is a branded intravenous antibiotic used in hospital settings for resistant bacterial infections; none of the recent opportunities reflect procurement of this specific pharmaceutical product. The mismatch suggests the code may be misapplied in the tagging system or the recent opportunities represent tag pollution rather than authentic activity under this commodity code.

The issuing bodies in the recent opportunities span state health agencies (Texas HHS, Minnesota Department of Administration), county health systems (Seminole County), city fire departments (Tampa), and multistate cooperative purchasing vehicles (MMCAP serving Minnesota, Oregon, and participating jurisdictions). Geographic activity centers on Florida, Texas, and Minnesota, with cooperative purchasing extending across multiple states. Representative opportunities include the Seminole County IFB for 1,900 units of naloxone and 800 drug deactivation systems annually (due July 26, 2023), the City of Tampa IFB for 169 line items of medical and first aid supplies totaling $700,000 with an SLBE set-aside and 5 percent discount (due March 13, 2026), and the MMCAP RFP for generic pharmaceuticals and OTC products with proposals due March 26, 2026. No recent opportunities show procurement of telavancin itself. Business development professionals should not pursue opportunities under this code based on the recent activity record — the code shows no relevant market signal for telavancin vendors.